STEWARTVILLE, Minn., Oct. 28 /PRNewswire-FirstCall/ --
Rochester Medical Corporation (Nasdaq: ROCM - News) will announce quarterly results after financial markets close on Thursday, November 5th, 2009. The Company will then hold a quarterly conference call to discuss its earnings report. The call will begin at 3:30 p.m. central time (4:30 p.m. eastern time).
This call is being webcast by Thomson/CCBN and can be accessed at Rochester Medical's website at www.rocm.com. To listen live to the conference call via telephone, call:
Domestic: 888.680.0893
International: 617.213.4859
Pass code: 64235793
Pre Registration: https://www.theconferencingservice.com/prereg/key.process?key=PD8MG6W7Q
Replay will be available for seven days at www.rocm.com or via telephone
at:
Domestic: 888-286-8010
International: 617-801-6888
Pass code: 31548516
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).
Rochester Medical Corporation develops, manufactures, and markets latex-free disposable medical catheters and devices for urological and continence care applications. The Company markets under its own Rochester Medical(®) brand and under existing private label arrangements.
For further information, please contact Anthony J. Conway, President and Chief Executive Officer of Rochester Medical Corporation at (507) 533-9600. More information about Rochester Medical is available on its website at http://www.rocm.com.
Copyright © 2009 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.